Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study

被引：0
|
作者：
Miroslava Hejdova
Vladimir Palicka
Zdenek Kucera
Jiri Vlcek
机构：
[1] Charles University in Prague,Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove
[2] Charles University,Osteocentre, University Hospital
来源：
Pharmacy World and Science | 2005年 / 27卷
关键词：
Alendronate; Bone mineral density; Calcitonin; Czech Republic; Observational study; Postmenopausal osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Alendronate and calcitonin are antiresorptive drugs that were used for the treatment of postmenopausal osteoporosis and were shown to increase bone mineral density (BMD). However, the effect of both drugs in daily clinical practice may differ from that observed in clinical trials.
引用
收藏
页码：149 / 153
页数：4
相关论文
共 50 条
  • [21] The relation between high cholesterol level and bone mineral density (BMD) in postmenopausal osteoporotic women.
    Cerrahoglu, L
    Duruöz, MT
    Senocak, I
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 29 - 29
  • [22] Effect of sodic alendronate on bone mineral density in postmenopausal women
    Sakamoto, LC
    Carvalho, CP
    Ribeiro, MNR
    Gennari, MB
    Mantese, JC
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S123 - S123
  • [23] Alendronate vs Calcitonin in the treatment of the osteoporotic postmenopausal bone pain
    Aurilio, C
    Massimo, F
    Passavanti, MB
    Primerano, B
    De Luca, E
    Serio, L
    Giacometti, S
    Chiefari, M
    [J]. MANAGEMENT OF PAIN A WORLD PERSPECTIVE III, 1998, : 495 - 498
  • [24] Hip geometry and bone mineral density in postmenopausal women.
    Brownbill, RA
    Lindsey, C
    Ilich, JZ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S467 - S467
  • [25] Longitudinal study of bone mineral density among postmenopausal Japanese women.
    Honda, S
    Tagawa, M
    Aoyagi, K
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S296 - S296
  • [26] Vitamin A intake and bone mineral density in postmenopausal women.
    Rapuri, PB
    Gallagher, JC
    Haynatzka, V
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S458 - S458
  • [27] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [28] Effects of alendronate and hormone replacement therapy on the bone mineral density of postmenopausal Iranian women
    Sharifi, F.
    Jaberi, Y.
    Perse, L.
    Ahmadi, G. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S48 - S49
  • [29] Alendronate Vs intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs, RW
    Favus, M
    Walsh, B
    Bell, NH
    Ettinger, MP
    Wang, L
    Mako, B
    Smith, ME
    Gormley, GJ
    Melton, ME
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S401 - S401
  • [30] Effects of focal vibration on bone mineral density and motor performance of postmenopausal osteoporotic women
    Brunetti, O.
    Botti, F. M.
    Brunetti, A.
    Biscarini, A.
    Scarponi, A. M.
    Filippi, G. M.
    Pettorossi, V. E.
    [J]. JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2015, 55 (1-2): : 118 - 127
12345